PMID- 19596066 OWN - NLM STAT- MEDLINE DCOM- 20100126 LR - 20211020 IS - 1873-4596 (Electronic) IS - 0891-5849 (Print) IS - 0891-5849 (Linking) VI - 47 IP - 7 DP - 2009 Oct 1 TI - Mitochondrial dihydrolipoyl succinyltransferase deficiency accelerates amyloid pathology and memory deficit in a transgenic mouse model of amyloid deposition. PG - 1019-27 LID - 10.1016/j.freeradbiomed.2009.07.008 [doi] AB - Mitochondrial dysfunction and oxidative stress are involved in Alzheimer disease (AD) pathogenesis. In human AD brains, the activity of the alpha-ketoglutarate dehydrogenase enzyme complex (alpha-KGDHC) is reduced. KGDHC is mostly involved in NADH production. It can also participate in oxidative stress and reactive oxygen species (ROS) production. The mitochondrial dihydrolipoyl succinyltransferase enzyme (DLST) is a key subunit specific to the alpha-KGDHC. In cultured cells, reduction of DLST increased H(2)O(2)-induced ROS generation and cell death. Thus, we asked whether partial genetic deletion of DLST could accelerate the onset of AD pathogenesis, using a transgenic mouse model of amyloid deposition crossed with DLST(+/-) mice. Tg19959 mice, which carry the human amyloid precursor protein with two mutations, develop amyloid deposits and progressive behavioral abnormalities. We compared Tg19959 mice to Tg19959-DLST(+/-) littermates at 2-3 months of age and studied the effects of DLST deficiency on amyloid deposition, spatial learning and memory, and oxidative stress. We found that alpha-KGDHC activity was reduced in DLST(+/-) mice. We also found that DLST deficiency increased amyloid plaque burden, Abeta oligomers, and nitrotyrosine levels and accelerated the occurrence of spatial learning and memory deficits in female Tg19959 mice. Our data suggest that alpha-KGDHC may be involved in AD pathogenesis through increased mitochondrial oxidative stress. FAU - Dumont, Magali AU - Dumont M AD - Department of Neurology and Neuroscience, Weill Cornell Medical College,New York, NY 10065, USA. mad2138@med.cornell.edu FAU - Ho, Daniel J AU - Ho DJ FAU - Calingasan, Noel Y AU - Calingasan NY FAU - Xu, Hui AU - Xu H FAU - Gibson, Gary AU - Gibson G FAU - Beal, M Flint AU - Beal MF LA - eng GR - P01 AG014930/AG/NIA NIH HHS/United States GR - P01 AG014930-08/AG/NIA NIH HHS/United States GR - 5P01 AG14930-08/AG/NIA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20090722 PL - United States TA - Free Radic Biol Med JT - Free radical biology & medicine JID - 8709159 RN - 0 (Amyloid beta-Peptides) RN - 0 (Peptide Fragments) RN - 0 (amyloid beta-protein (1-40)) RN - 0 (amyloid beta-protein (1-42)) RN - EC 2.3.- (Acyltransferases) RN - EC 2.3.1.61 (dihydrolipoamide succinyltransferase) SB - IM MH - Acyltransferases/*deficiency/metabolism MH - Alzheimer Disease/metabolism MH - Amyloid beta-Peptides/genetics/*metabolism MH - Amyloidosis/metabolism/*pathology/*physiopathology MH - Animals MH - Disease Models, Animal MH - Female MH - Male MH - Memory Disorders/genetics/*metabolism/physiopathology MH - Mice MH - Mice, Transgenic MH - Mitochondria/*enzymology/metabolism MH - Oxidative Stress MH - Peptide Fragments/genetics/*metabolism PMC - PMC2761144 MID - NIHMS132172 EDAT- 2009/07/15 09:00 MHDA- 2010/01/27 06:00 PMCR- 2010/10/01 CRDT- 2009/07/15 09:00 PHST- 2009/05/08 00:00 [received] PHST- 2009/07/06 00:00 [revised] PHST- 2009/07/07 00:00 [accepted] PHST- 2009/07/15 09:00 [entrez] PHST- 2009/07/15 09:00 [pubmed] PHST- 2010/01/27 06:00 [medline] PHST- 2010/10/01 00:00 [pmc-release] AID - S0891-5849(09)00411-0 [pii] AID - 10.1016/j.freeradbiomed.2009.07.008 [doi] PST - ppublish SO - Free Radic Biol Med. 2009 Oct 1;47(7):1019-27. doi: 10.1016/j.freeradbiomed.2009.07.008. Epub 2009 Jul 22.